These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 26143384

  • 1. Short-Term Treprostinil Use in Infants with Congenital Diaphragmatic Hernia following Repair.
    Olson E, Lusk LA, Fineman JR, Robertson L, Keller RL.
    J Pediatr; 2015 Sep; 167(3):762-4. PubMed ID: 26143384
    [Abstract] [Full Text] [Related]

  • 2. Safety and tolerability of subcutaneous treprostinil in newborns with congenital diaphragmatic hernia and life-threatening pulmonary hypertension.
    Carpentier E, Mur S, Aubry E, Pognon L, Rakza T, Flamein F, Sharma D, Tourneux P, Storme L.
    J Pediatr Surg; 2017 Sep; 52(9):1480-1483. PubMed ID: 28389079
    [Abstract] [Full Text] [Related]

  • 3. Treprostinil Improves Persistent Pulmonary Hypertension Associated with Congenital Diaphragmatic Hernia.
    Lawrence KM, Hedrick HL, Monk HM, Herkert L, Waqar LN, Hanna BD, Peranteau WH, Rintoul NE, Hopper RK.
    J Pediatr; 2018 Sep; 200():44-49. PubMed ID: 29784517
    [Abstract] [Full Text] [Related]

  • 4. Epoprostenol Does Not Affect Mortality in Neonates with Congenital Diaphragmatic Hernia.
    Skarda DE, Yoder BA, Anstadt EE, Lally PA, Greene T, McFadden M, Rollins MD.
    Eur J Pediatr Surg; 2015 Oct; 25(5):454-9. PubMed ID: 25217715
    [Abstract] [Full Text] [Related]

  • 5. Short term effect of intravenous treprostinil in term and preterm infants with pulmonary hypertension.
    Kim YJ, Shin SH, Kim EK, Kim HS.
    BMC Pediatr; 2024 Jan 29; 24(1):83. PubMed ID: 38281939
    [Abstract] [Full Text] [Related]

  • 6. Treprostinil in Neonates with Congenital Diaphragmatic Hernia-Related Pulmonary Hypertension.
    De Bie FR, Avitabile CM, Flohr S, Land S, Mathew L, Wang Y, Ash D, Rintoul NE, Hedrick HL.
    J Pediatr; 2023 Aug 29; 259():113420. PubMed ID: 37059388
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Prostaglandin 12 analogs (epoprostenol and treprostinil) as a treatment for refractory bronchopulmonary dysplasia-induced pulmonary hypertension in an infant].
    Puente Ubierna N, Bachiller Carnicero L, Corredera Sánchez A, Martínez Orgado JA, Del Cerro Marín MJ.
    Arch Argent Pediatr; 2019 Aug 01; 117(4):e413-e415. PubMed ID: 31339286
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.
    Gessler T, Seeger W, Schmehl T.
    Ther Adv Respir Dis; 2011 Jun 01; 5(3):195-206. PubMed ID: 21300738
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan.
    Benza RL, Rayburn BK, Tallaj JA, Pamboukian SV, Bourge RC.
    Chest; 2008 Jul 01; 134(1):139-45. PubMed ID: 18403673
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Time versus treatment: interpreting longitudinal data analysis of treprostinil.
    Madenci AL, Baer HJ, Vitali SH, Zalieckas JM, Arnold JH, Weldon CB.
    J Pediatr; 2019 Mar 01; 206():304-305. PubMed ID: 30559020
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.